These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17919858)

  • 1. Application of instrumental evaluation of color for the pre-formulation and formulation of rabeprazole.
    Rhee YS; Park CW; Shin YS; Kam SH; Lee KH; Park ES
    Int J Pharm; 2008 Feb; 350(1-2):122-9. PubMed ID: 17919858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium.
    Ren S; Park MJ; Sah H; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):197-204. PubMed ID: 17928178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolic stability of moisture-sensitive rabeprazole in human liver microsomes and its modulation by pharmaceutical excipients.
    Ren S; Park MJ; Kim A; Lee BJ
    Arch Pharm Res; 2008 Mar; 31(3):406-13. PubMed ID: 18409057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques.
    Vasu Dev R; Sai Uday Kiran G; Venkata Subbaiah B; Suresh Babu B; Moses Babu J; Dubey PK; Vyas K
    Magn Reson Chem; 2009 May; 47(5):443-8. PubMed ID: 19173350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemometric determination of rabeprazole sodium in presence of its acid induced degradation products using spectrophotometry, polarography and anodic voltammetry at a glassy carbon electrode.
    Moneeb MS
    Pak J Pharm Sci; 2008 Jul; 21(3):214-24. PubMed ID: 18614415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural elucidation of rabeprazole sodium photodegradation products.
    Garcia CV; Nudelman NS; Steppe M; Schapoval EE
    J Pharm Biomed Anal; 2008 Jan; 46(1):88-93. PubMed ID: 17945453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.
    Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M
    J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoinduced color changes in two different qualities of riboflavin in the solid state and in various tablet formulations photoreactivity of biologically active compounds. XX.
    Sue-Chu M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jul; 64(7):428-35. PubMed ID: 19694178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects.
    Mukherjee J; Das A; Chakrabarty US; Sahoo B; Sengupta P; Chatterjee B; Roy B; Pal TK
    Arzneimittelforschung; 2010; 60(8):506-9. PubMed ID: 20863007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation.
    Airaksinen S; Karjalainen M; Kivikero N; Westermarck S; Shevchenko A; Rantanen J; Yliruusi J
    AAPS PharmSciTech; 2005 Oct; 6(2):E311-22. PubMed ID: 16353990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stress stability of olanzapine: studies of interactions with excipients in solid state pharmaceutical formulations.
    Djordjević Filijović N; Antonijević MD; Pavlović A; Vučković I; Nikolić K; Agbaba D
    Drug Dev Ind Pharm; 2015 Mar; 41(3):502-14. PubMed ID: 24611817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
    Chen J; Zhang LH; Xu RJ; Bu NJ; Zhang L
    Pharmazie; 2014 Apr; 69(4):277-80. PubMed ID: 24791591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of a 5 mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers: a single-dose randomized open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; de Mena F; Simoni MV; Assefi AR; Di Girolamo G
    Curr Med Res Opin; 2011 Nov; 27(11):2203-11. PubMed ID: 21970660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.